Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Niraparib & Ovarian Cancer, niraparib is FDA approved as maintenance therapy of ovarian cancer after first‑line platinum‑based chemotherapy for patients who are in complete or partial response (1)
Both first‑line and recurrent platinum‑sensitive maintenance are EMA labeled regardless of BRCA status, though national reimbursement or local guidelines may still influence biomarker‑driven use (2, 3)
Niraparib maintenance treatment, irrespective of genetic profile, provides a novel approach for treating ovarian cancer, fe…